How Vertical Integration—and AARP—Are Driving Up Your Drug Costs

REALCLEARHEALTH

Every year, millions of patients pay their health insurance premiums, trusting their insurer will be there to support them if something happens. What they don't know is that the same company they’re depending on is pocketing their premiums and taking a cut of their prescription payments. For the tens of millions of Americans enrolled in UnitedHealthcare plans, their prescriptions are being routed through UnitedHealth’s own pharmacy benefit manager (PBM), OptumRx, generating billions in financial windfall.

Unfortunately, UnitedHealth is not an outlier but the blueprint for major health insurers. Across the country, the same vertical integration model, where an insurer operates through its own PBM—which also owns a pharmacy—has quietly become the routine structure of American healthcare and the reason patients continue to be charged outrageous prices at the pharmacy counter. This model lets one company set the price, choose the drug, and pocket the difference, with no market check on any of it. As this consolidation has grown, competition has shrunk, driving up costs, reducing competition, and eroding transparency.

Healthcare affordability depends on transparency and choice. Competitive markets provide consumers with greater options, reward investment in innovation, and hold companies accountable, leading to lower prices over time. But vertically integrated mega-insurers offer none of the above. Instead, they grant patients little visibility into the decision-making process while single-handedly setting premiums, controlling drug coverage and cost, and dictating which pharmacy a patient can use.

The result is a system where decisions that directly impact patients are made behind closed doors, leaving patients to navigate costs and coverage rules they didn’t choose. When the same corporation is present at every stage of the transaction, it becomes increasingly difficult for patients to know whether decisions are being made in their best interest or in the interest of maximizing corporate revenue.

Fixing rising healthcare costs means accountability shouldn’t stop with only insurers. It must also extend to organizations that have profited from a business model that reduces competition, obscures costs, and leaves patients with fewer choices.

This is where AARP enters the picture. By leveraging its trusted brand with UnitedHealth, AARP has collected an estimated $10.8 billion in tax-free revenue from the mega-insurer since 2007 and become not a bystander, but an influential player in a system working against patients.

Read more here.